You have 9 free searches left this month | for more free features.

Fibrates

Showing 1 - 25 of 94

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aortic Valve Stenosis Trial in Oxford (Fenofibrate Capsules, Placental Lactogen)

Active, not recruiting
  • Aortic Valve Stenosis
  • Fenofibrate Capsules
  • Placental Lactogen
  • Oxford, United Kingdom
    OUH NHS trust
Feb 15, 2022

Prospective German Very High Cardiovascular Risk Patients

Recruiting
  • Dyslipoproteinemias
  • PCSK9 Inhibitor [EPC]
  • Standard lipid lowering therapy
  • Dresden, Germany
    Medizinische Klinik und Poliklinik III
Mar 18, 2022

Glucose Metabolism Disorders Trial in Pisa (Intermittent Fasting, Fibrates, Low-Carbohydrate/High-Protein diet)

Enrolling by invitation
  • Glucose Metabolism Disorders
  • Intermittent Fasting
  • +2 more
  • Pisa, PI, Italy
    Azienda Ospedaliero-Universitaria Pisana
Jan 25, 2022

IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)

Recruiting
  • Inflammatory Bowel Diseases
  • Tanta, Egypt
    Tanta Unuversity
Mar 6, 2023

IBD Trial in Tanta (Mesalamine, Fenofibrate)

Recruiting
  • Inflammatory Bowel Diseases
  • Tanta, Shebeen El-Kom, Egypt
    Faculty of Medicine, Menoufia University
Mar 11, 2023

Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction Trial in Padova (Fenofibrate 145 mg, Placebo)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Fenofibrate 145 mg
  • Placebo
  • Padova, Padua, Italy
    University Hospital of Padova
Sep 13, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Enrolling by invitation
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Dec 15, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Completed
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Jul 30, 2022

Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

Recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Inclisiran
  • Geneve 14, Switzerland
    Novartis Investigative Site
Nov 14, 2022

Peripheral Arterial Disease Trial in Hoffman Estates

Recruiting
  • Peripheral Arterial Disease
    • Hoffman Estates, Illinois
      Outpatient Endovascular Interventional Society (OEIS)
    Sep 27, 2022

    sCD163 in PBC Patients - Assessment of Treatment Response

    Recruiting
    • Primary Biliary Cirrhosis
    • +2 more
    • Blood samples
    • +3 more
    • Aarhus C, Region Midtjylland, Denmark
      Department of Hepatology and Gastroenterology, Aarhus University
    Aug 11, 2022

    Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

    Not yet recruiting
    • Breast Cancer Stage 2 and 3
    • (no location specified)
    Nov 24, 2023

    Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)

    Recruiting
    • Acute Ischemic Stroke
    • Basilar Artery Occlusion
    • Best medical management
    • Endovascular treatment
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Oct 20, 2023

    The Serum Lipid Profiles in ITP: a Retrospective Study

    Completed
    • Immune Thrombocytopenia
    • ITP patients
    • Jinan, Shandong, China
      Qilu hospital of Shandong university
    Oct 14, 2021

    The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive

    Completed
    • The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
    • Zingiber officinale L. tablets
    • Simvastatin 20mg
    • Karachi, Sindh, Pakistan
      Alkhidmat Hospital
    Jan 11, 2023

    Chronic Cholestasis Trial in Cairo, Shibin Al Kawm (Lipanthyl, Ursogal)

    Completed
    • Chronic Cholestasis
    • Cairo, Nasr City, Egypt
    • +1 more
    Jul 14, 2018

    Effectiveness in Patients With Metabolic Syndrome (TRISTAN)

    Completed
    • Hypertriglyceridemia
    • Metabolic Syndrome
    • Tricor (fenofibrate), 145 mg, film-coated tablet
    • Barnaul, Russian Federation
    • +62 more
    Dec 14, 2021

    Coronavirus Infection Trial in Brooklyn (Colchicine, Usual Care)

    Terminated
    • Coronavirus Infection
    • Brooklyn, New York
      Maimonides Medical Center
    Feb 16, 2022

    Type 1 Hyperlipoprotenemia Trial (Orlistat, Placebo)

    Not yet recruiting
    • Type 1 Hyperlipoprotenemia
    • (no location specified)
    Apr 14, 2023

    Diabetes, Type 2 Trial in Jinan (behavioral, drug, other)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Lifestyle therapy
    • +3 more
    • Jinan, Shandong, China
    • +1 more
    Jul 5, 2021

    Medication Adherence Trial in Murray (Nudges Intervention)

    Completed
    • Medication Adherence
    • Nudges Intervention
    • Murray, Utah
      Intermountain Heart Institute
    Oct 28, 2020

    HIV, Lipodystrophy Trial in Puerto Rico, United States (Pravastatin sodium, Fenofibrate)

    Completed
    • HIV Infections
    • Lipodystrophy
    • Birmingham, Alabama
    • +57 more
    Oct 28, 2021

    Primary Biliary Cholangitis Trial in Italy (Clinical information)

    Recruiting
    • Primary Biliary Cholangitis
    • Clinical information
    • Ancona, Italy
    • +42 more
    Nov 25, 2021

    Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

    Recruiting
    • Diabetic Nephropathies
    • Boston, Massachusetts
    • +1 more
    Aug 15, 2022

    HIV, Fenofibrate, Protease Inhibitors Trial run by the CC (Fenofibrate, Ritonavir, Lopinavir/Ritonavir)

    Completed
    • HIV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 6, 2019